If it seems like more and more children are allergic to peanuts, you are probably correct. In a recent study, Dr. Ruchi Gupta surveyed more than 53,000 U.S. households and found that peanut allergies in children were up 21 percent and rates of tree nut, shellfish, fin fish and sesame allergies are also increasing. It was interesting to note that the risk of peanut allergy was nearly double among black children as compared to white children since 2010.However the good news is two new products were recently approved by the FDA that could potentially prevent peanut allergy by introducing peanut products to infants at an early age.
New research currently being presented at the American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting suggests that peanut allergies in children have increased by 21 percent since 2010, with nearly 2.5 percent of children in the United States potentially now suffering from the condition.
It certainly makes life a little more difficult if we can’t pack a peanut butter and jelly sandwich in our children’s lunch box, but if it can save the life of a child with allergies it is all worth it. However, a recent study found that schools with peanut-free policies actually had higher epinephrine use for the treatment of anaphylaxis caused by peanuts and tree nuts. Schools with peanut-free tables in the cafeteria had lower epinephrine use. This could be due to food with peanuts being brought in accidently to peanut-free schools, or a false sense of security in schools with these policies. The study concludes with the suggestion that it might be best for schools to focus on awareness and training of their school staff, rather than banning peanuts entirely.
Researchers in Australia have come up with a new therapy for peanut allergies that combines probiotics with small doses of peanuts to gradually train the child’s immune systems to not treat it as something foreign. The results are encouraging, allowing the children who were treated to eat peanuts without fear of an allergic reaction. But it may be too early to call this a cure.
In a long-term study of the latest treatment for peanut allergy, scientists in Australia report that an immune-based therapy helped children allergic to peanuts eat them without reactions for four years.
The study, published in the journal Lancet Child & Adolescent Health, follows up on children enrolled in an earlier study of an immunotherapy treatment, which combined probiotics with small doses of peanuts that were designed to gradually train the children’s immune systems to accept the peanut allergen rather than treat it as something foreign. Previous studies have suggested that methods like these could be effective in reducing youngsters' allergic, sometimes dangerous anaphylactic shock reactions to peanuts. The Australian team added probiotics to further enhance the gut’s ability to accept the peanuts and not trigger an immune reaction. Compared to 4% of children who didn’t get any treatment, 82% of those receiving the combination therapy significantly reduced their allergic reactions to peanuts.
It was wonderful that the Emergency Allergy Treatment Act (EATA) was passed last September, enabling New York State’s public facilities to stock and administer epinephrine. This will be especially important to day care centers, where young children can have undiagnosed allergies to food or insect stings. While many centers are taking advantage of training provided by the Child Care Council of Rochester, they will have to come up with their own funding in order to purchase EpiPens. If you know of a business or foundation that might be willing to make a charitable donation for this important purpose, please let us know. You can read the full article here.
Emergency Allergy Treatment Act Becomes a Reality
By Janet Goldman August 22, 2017
There is an old saying that goes something like this: “Children are the most precious of all” (author unknown). Due to our economy’s demands, countless children spend many hours in day care centers. With trust, parents choose these centers, expecting quality attention. To better ensure safety for those with life-threatening allergies, parents provide epinephrine auto-injectors. But what about protecting those that don’t know they are at risk?
“When in doubt, get it out!” A recent study published in the Annals of Allergy, Asthma & Immunology found that fewer than half the children received epinephrine prior to arriving at an emergency room, even though approximately 65 percent had a known history of anaphylaxis, and 47 percent had been prescribed epinephrine. This was mostly true when the emergency occurred at home rather than school, with parents, caregivers and even emergency responders showing reluctance to administer the life-saving medication.
July 12, 2017 Journal Reference: Melissa Robinson, Matthew Greenhawt, David R. Stukus. Factors associated with epinephrine administration for anaphylaxis in children before arrival to the emergency department. Annals of Allergy, Asthma & Immunology, 2017; DOI: 10.1016/j.anai.2017.06.001 Source: American College of Allergy, Asthma, and Immunology Summary: Even kids who were prescribed an epinephrine auto injector didn't receive the life-saving medication when they needed it, new research has found.
Anyone suffering a severe allergic reaction (anaphylaxis) should receive epinephrine as quickly as possible. A new study showed that even kids who were prescribed an epinephrine auto injector didn't receive the life-saving medication when they needed it.